MARKET

NDRA

NDRA

ENDRA Life
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9735
-0.0105
-1.07%
Closed 16:00 08/07 EDT
OPEN
0.9800
PREV CLOSE
0.9840
HIGH
1.000
LOW
0.9550
VOLUME
164.44K
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
0.5990
MARKET CAP
15.94M
P/E (TTM)
-0.4363
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NDRA stock price target is 4.375 with a high estimate of 6.00 and a low estimate of 2.750.

EPS

NDRA News

More
ENDRA nabs European patent covering its ultrasound system
ENDRA Life Sciences (NDRA -0.4%) has been issued European Patent 3328285 from the European Patent Office, for its Thermo Acoustic Enhanced UltraSound (TAEU
seekingalpha · 07/22 21:16
ENDRA Live Sciences Granted Additional European Patent As Commercialization Begins
Benzinga · 07/22 13:06
ENDRA Life Sciences Submits 510(k) Application To FDA For TAEUS Liver Device
Benzinga · 06/30 12:17
ENDRA Life Sciences Announces Addition Of New Patents
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities ANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a
Benzinga · 06/23 12:20
ENDRA Life Sciences' NASH Test Device, TAEUS, At Commercialization Inflection Point
Seeking Alpha - Article · 06/20 00:40
ENDRA Life teams up with Medical College of Wisconsin for TAEUS device
Seeking Alpha - Article · 06/08 14:21
ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin
Benzinga · 06/08 12:09
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/16 17:46

Industry

Biotechnology & Medical Research
-0.19%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Symbol
Price
%Change

About NDRA

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.
More

Webull offers kinds of ENDRA Life Sciences Inc stock information, including NASDAQ:NDRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NDRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NDRA stock methods without spending real money on the virtual paper trading platform.